Watch Evan Guggenheim (Biogen Idec), Robert Boland (Johnson & Johnson) and Steve Thomas (GSK) present and discuss the challenges and problems with integrating new data management solutions in the laboratory. The panel discuss change management and the complexities involved in implementing LIMS and ELN solutions. 

Andrew Porter, Director of Enterprise Architecture at Merck, talks about the key issues his company is facing with respect to managing Big Data. For Andrew, dealing with data poses challenging questions about regulatory compliance, privacy and accessibility of the data. 

Gernot Goeller, Head O&I CoE ED&CMC at Bayer Pharma who played a vital role when his organisation made the transition to a paperless lab shares his advice and discusses the main benefits of developing a paperless lab. Gernot also finishes off by telling us how he thinks the vendor community can help him address his most pressing challenges.

Andrew discusses the pressures pharmaceutical companies are currently facing with respect to Big Data. The explosion of data in recent years has caused serious challenges in the security, analytics and management of sensitive information. This presentation offers an exclusive insight into one of the main issues pharmaceutical companies are attempting to overcome.  

This presentation from Steve Thomas, Principal Investigator at GSK, focuses on how laboratory scientists are changing the way they enter their clinical data. Steve discusses the role of new software and its impact on research.

Listen to Dana Vanderwall, Director of Bioinformatics at Bristol-Myers Squibb, and Wolfgang Colsman, CTO at OSTHUS GmbH, talk about the benefits of data standardisation and how to integrate different data systems.

Join Eric Milgram (PepsiCo), Vijay Bulusu (Pfizer), Anthony Williams (Royal Society of Chemistry) and Dimitris Agrafiotis (Covance) as they discuss the biggest challenges with data conversion and how they drive intelligence and improve R&D productivity.